Surgical Mesh Implants: Australia and New Zealand
(asked on 22nd February 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implication for his polices of the decision of Boston Scientific to cease marketing urogynecological mesh products in (a) Australia and (b) New Zealand as of 31 December 2021; and will he make a statement.
Answered by
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Medicines and Healthcare products Regulatory Agency (MHRA) is aware of the decision from Boston Scientific to cease marketing some uro-gynaecological meshes from the Australian and New Zealand market. The MHRA understands this is a commercial decision not related to the safety of the device and is not applicable to the United Kingdom market.